Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

被引：0
|
作者：
Michael F. Gowen
Keith M. Giles
Danny Simpson
Jeremy Tchack
Hua Zhou
Una Moran
Zarmeena Dawood
Anna C. Pavlick
Shaohui Hu
Melissa A. Wilson
Hua Zhong
Michelle Krogsgaard
Tomas Kirchhoff
Iman Osman
机构：
[1] New York University School of Medicine,The Ronald O. Perelman Department of Dermatology
[2] New York University School of Medicine,Applied Bioinformatics Core
[3] New York University School of Medicine,Division of Hematology & Oncology, Perlmutter Cancer Center
[4] New York University School of Medicine,Division of Epidemiology
[5] New York University School of Medicine,Department of Population Health
[6] New York University School of Medicine,Department of Pathology
[7] CDI Laboratories,Department of Medicine
[8] New York University School of Medicine,undefined
来源：
Journal of Translational Medicine | / 16卷
关键词：
Melanoma; Immunotherapy; Antibodies; Toxicity; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
    Gowen, Michael F.
    Giles, Keith M.
    Simpson, Danny
    Tchack, Jeremy
    Zhou, Hua
    Moran, Una
    Dawood, Zarmeena
    Pavlick, Anna C.
    Hu, Shaohui
    Wilson, Melissa A.
    Zhong, Hua
    Krogsgaard, Michelle
    Kirchhoff, Tomas
    Osman, Iman
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [2] Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors
    Nunez, Nicolas Gonzalo
    Berner, Fiamma
    Friebel, Ekaterina
    Unger, Susanne
    Wyss, Nina
    Gomez, Julia Martinez
    Purde, Mette-Triin
    Niederer, Rebekka
    Porsch, Maximilian
    Lichtensteiger, Christa
    Kramer, Rafaela
    Erdmann, Michael
    Schmitt, Christina
    Heinzerling, Lucie
    Abdou, Marie-Therese
    Karbach, Julia
    Schadendorf, Dirk
    Zimmer, Lisa
    Ugurel, Selma
    Kluemper, Niklas
    Hoelzel, Michael
    Power, Laura
    Kreutmair, Stefanie
    Capone, Mariaelena
    Madonna, Gabriele
    Cevhertas, Lacin
    Heider, Anja
    Amaral, Teresa
    Ali, Omar Hasan
    Bomze, David
    Dimitriou, Florentia
    Diem, Stefan
    Ascierto, Paolo Antonio
    Dummer, Reinhard
    Jaeger, Elke
    Driessen, Christoph
    Levesque, Mitchell Paul
    van de Veen, Willem
    Joerger, Markus
    Frueh, Martin
    Becher, Burkhard
    Flatz, Lukas
    MED, 2023, 4 (02): : 113 - +
  • [3] Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors
    Machet, L.
    Zaragoza, J.
    Finon, A.
    Garnier, M.
    Maillard, H.
    Caille, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 224 - 224
  • [4] Toxicity management in patients treated with immune checkpoint inhibitors
    Rothschild, S., I
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 147 - 148
  • [5] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [6] Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
    Asher, Nethanel
    Marom, Edith M.
    Ben-Betzalel, Guy
    Baruch, Erez Nissim
    Steinberg-Silman, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Markel, Gal
    ONCOLOGIST, 2019, 24 (05): : 640 - 647
  • [7] Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
    Johannet, Paul
    Liu, Wenke
    Fenyo, David
    Wind-Rotolo, Megan
    Krogsgaard, Michelle
    Mehnert, Janice M.
    Weber, Jeffrey S.
    Zhong, Judy
    Osman, Iman
    CLINICAL CANCER RESEARCH, 2022, 28 (18) : 4121 - 4130
  • [8] Pulmonary toxicity in patients treated with immune checkpoint inhibitors and radiation
    Senan, S.
    Bahce, I.
    ANNALS OF ONCOLOGY, 2020, 31 (12) : 1597 - 1598
  • [9] BASELINE GLYCOLYTIC TUMOR BURDEN PREDICTS RESPONSE AND SURVIVAL IN NSCLC AND MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Silva, Saulo
    Wanderley, Carlos Wagner
    Marin, Jose Flavio
    De Macedo, Mariana
    Nascimento, Ellen
    Antonacio, Fernanda
    Cunha, Fernando
    de Castro, Gilberto
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A62 - A63
  • [10] Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
    Spillane, Susan
    Baxi, Shrujal
    Torres, Aracelis Z.
    Lenis, David
    Freedman, Andrew N.
    Mariotto, Angela B.
    Sharon, Elad
    ONCOLOGIST, 2020, 25 (11): : E1753 - E1762
12345